ArticleSignal transduction and targeted therapy2025

Engineered extracellular vesicles reprogram T cells by targeting PD-1 and PHB1 signaling in inflammatory bowel disease.

Mi-Kyung Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.